Target intelligence / Profile preview

Glucose-induced degradation protein 8 homolog (GID8)

Target
GID8
Molecular classification
Other (CTLH E3 ubiquitin-protein ligase complex subunit; not a receptor, ion channel, enzyme, or transporter)
01

Overview

Glucose-induced degradation protein 8 homolog (GID8) is a core component of the CTLH (C-terminal to LisH) E3 ubiquitin-protein ligase complex, which is responsible for substrate recognition, ubiquitin transfer, and mediating proteasomal degradation of specific transcription factors—most notably HBP1. GID8 plays a crucial role in **regulating the canonical Wnt signaling pathway** by acting as a nuclear retention factor for β-catenin. Upon Wnt stimulation, GID8/Twa1 facilitates the nuclear accumulation and retention of β-catenin, which is essential for Wnt-regulated transcriptional activation involved in cell proliferation and tumorigenesis. Upregulation of nuclear GID8 is correlated with increased β-catenin nuclear localization and poor prognosis in colorectal cancer. It participates in protein homodimerization and positively regulates cell population proliferation. GID8 is not a classic receptor or enzyme but functions in multiprotein complexes associated with cell signaling and protein degradation. There are no known drugs that selectively target GID8, and it is not established as a drug target or clinical biomarker.

Other names
C20orf11TWA1Two hybrid-associated protein 1 with RanBPMFLJ20602bA305P22.1Two hybrid associated protein No. 1 with RanBPMprotein C20orf11GID complex subunit 8 homologTwa1
02

Biological functions

Component of CTLH E3 ubiquitin-protein ligase complexPositive regulation of canonical Wnt signaling pathway, specifically by promoting nuclear β-catenin accumulationPositive regulation of cell population proliferationProtein homodimerization activityMediation of ubiquitination and proteasomal degradation of transcription factor HBP1
03

Disease associations

Cancer (upregulated in colorectal carcinogenesis, facilitates β-catenin nuclear retention in Wnt signaling with relevance to tumorigenesis)Lissencephaly (associations in genetic studies, but mechanistic connection unclear)

Beyond the preview

Go deeper on Glucose-induced degradation protein 8 homolog (GID8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose-induced degradation protein 8 homolog (GID8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call